Sign in
4

Changes in Ownership

Vanda Pharmaceuticals Inc. Filed Acc 0000950170-24-063022

Director acquired 20,529 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Honore Tage Director 2024-05-17 Grant or award +20,529 64,244 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Honore Tage Director 2024-05-17 Grant or award · Stock Option (right to buy) +37,578 37,578 D: show line 2 in the form
Loading xslF345X05/ownership.xml…